microdosing glp 1 athletes THE GLP-1 PROGRAM People Are Microdosing Weight-Loss Drugs

These results were published in 1995 (Madsen Karlsen Blume)

Food and Drug Administration recently issued a warning against using unapproved GLP-1 drugs for weight loss, citing quality concerns, false or misleading labels, counterfeit drugs and more than 1,600 reports of adverse effects associated with compounded GLP-1 medications

weight loss

Using fatty acids to prolong the duration of the action of peptides and proteins was already a long established technique at Novo Nordisk and elsewhere and had been successfully applied to insulin (insulin detemir) (Knudsen, Lau)

Most patients can take both safely, but your doctor may suggest specific timing for your doses to ensure maximum effectiveness

Neuroscience Letters